Eupraxia Pharmaceuticals Inc (EPRX)

Mar 12, 2026

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results - Investing News Network

Mar 12, 2026

Mar 12, 2026

Eupraxia Widens Q4 Loss but Extends Cash Runway With $63 Million Financing - TipRanks

Mar 12, 2026

Mar 12, 2026

Eupraxia testing EoE drug extends cash runway to 2028 - Stock Titan

Mar 12, 2026

Mar 12, 2026

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results - GlobeNewswire Inc.

Mar 12, 2026

Mar 12, 2026

How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily

Mar 12, 2026

Mar 11, 2026

(EPRX) Market Insights and Trading Signals (EPRX:CA) - Stock Traders Daily

Mar 11, 2026

Mar 09, 2026

Canadian Investment Regulatory Organization Trading HaltEPRX.WT - marketscreener.com

Mar 09, 2026

Mar 09, 2026

Eupraxia Pharmaceuticals stock rating reiterated at Raymond James By Investing.com - Investing.com Canada

Mar 09, 2026

Mar 08, 2026

(EPRX) Stock Analysis and Trading Signals (EPRX:CA) - Stock Traders Daily

Mar 08, 2026

Mar 06, 2026

(EPRX.WT.A) Optimized Trading Opportunities - Stock Traders Daily

Mar 06, 2026

Mar 06, 2026

Eupraxia Pharmaceuticals Raises US$63.2 Million in February 2026 Equity Offering to Advance GI Pipeline - TipRanks

Mar 06, 2026

Mar 06, 2026

Aug Patterns: Whats the beta of Eupraxia Pharmaceuticals Inc stockGDP Growth & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Mar 06, 2026

Mar 03, 2026

(EPRX.WT.A) Trading Strategy and Analysis - Stock Traders Daily

Mar 03, 2026

Mar 02, 2026

Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering - Global Legal Chronicle

Mar 02, 2026

Mar 01, 2026

(EPRX.WT.A) Equity Market Report - Stock Traders Daily

Mar 01, 2026

Feb 28, 2026

(EPRX) Investment Performance Report (EPRX:CA) - Stock Traders Daily

Feb 28, 2026

Feb 26, 2026

(EPRX.WT.A) Trading Report (EPRX.WT.A:CA) - Stock Traders Daily

Feb 26, 2026

Feb 25, 2026

(EPRX) Proactive Strategies (EPRX:CA) - Stock Traders Daily

Feb 25, 2026

Feb 23, 2026

Bloom Burton initiates Eupraxia stock with buy rating on EoE drug - Investing.com Nigeria

Feb 23, 2026

Feb 23, 2026

Bloom Burton initiates Eupraxia stock with buy rating on EoE drug By Investing.com - Investing.com Australia

Feb 23, 2026

Feb 23, 2026

(EPRX.WT.A) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 23, 2026

Feb 22, 2026

EPRXEupraxia Pharmac Latest Stock News & Market Updates - Stock Titan

Feb 22, 2026

Feb 21, 2026

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Feb 21, 2026

Feb 21, 2026

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

Feb 21, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals closes $63.2M public offering - Investing.com India

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals closes $63.2M public offering By Investing.com - Investing.com Canada

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals stock gains after $63M offering - Investing.com Nigeria

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals stock gains after $63M offering By Investing.com - Investing.com Canada

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Raises US$63.2 Million to Advance GI Pipeline and Commercial Readiness - TipRanks

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Closes US$63.2M Public Offering Including Full Exercise of Underwriter Option - marketscreener.com

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Closes $63.2 Million Offering - marketscreener.com

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option - The Manila Times

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Announces Closing of US$63.2 - GlobeNewswire

Feb 20, 2026

Feb 20, 2026

Long Term Trading Analysis for (EPRX.WT.A) - Stock Traders Daily

Feb 20, 2026

Feb 20, 2026

Eupraxia Pharmaceuticals Launches Cross-Border Equity and Warrant Offering Under New Underwriting Pact - TipRanks

Feb 20, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals stock falls after pricing $55 million offering By Investing.com - Investing.com Canada

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals prices $55 million public offering - Investing.com Australia

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals Prices $55 Million Public Offering - marketscreener.com

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals stock falls after pricing $55 million offering - Investing.com India

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharma Prices $55 Mln Offering Of Shares And Warrants; Stock Down - Nasdaq

Feb 19, 2026

Feb 19, 2026

US Stocks Recap: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Eupraxia Prices $55 Mln Offering To Advance Diffusphere Pipeline - Nasdaq

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals announces pricing of US $55 million public offering of common shares and pre-funded warrants - marketscreener.com

Feb 19, 2026

Feb 19, 2026

Eupraxia Raises US$55 Million to Accelerate EP-104GI and GI Pipeline - TipRanks

Feb 19, 2026

Feb 19, 2026

Eupraxia Pharmaceuticals Announces Pricing Of US $55 Million Public Offering Of Common Shares And Pre-Funded Warrants - TradingView

Feb 19, 2026